VYNE Therapeutics Inc. (MNLO) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Merger agrmnt [a]
Appointed director

VYNE Therapeutics Inc. (MNLO)

Create: Alert

All | News | Filings

Date Filed	Type	Description
05/12/2022	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/15/2022	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/12/2021	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/05/2020	424B2	Form 424B2 - Prospectus [Rule 424(b)(2)]:
06/04/2020	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/07/2020	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/26/2018	424B4	Form 424B4 - Prospectus [Rule 424(b)(4)]:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy